 - Prior therapy with anti-Programmed death-1 anti-PD-1, anti-Programmed cell death ligand 1 anti-PD-L1, anti-Programmed cell death ligand 2 anti-PD-L2, anti-CD137, or anti-Cytotoxic T lymphocyte-associated antigen 4 anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell costimulation or checkpoint pathways 